Risk of Wernicke's encephalopathy and cardiac disorders in patients with myeloproliferative neoplasm
Authors:
- 1 April 2015
- journal article
- Published by Elsevier in Cancer Epidemiology
- Vol. 39 (2) , 242-249
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Incidence of haematological malignancy by sub-type: a report from the Haematological Malignancy Research NetworkBritish Journal of Cancer, 2011
- Myeloproliferative Neoplasms: Molecular Pathophysiology, Essential Clinical Understanding, and Treatment StrategiesJournal of Clinical Oncology, 2011
- Wernicke’s Encephalopathy: An Underrecognized and Reversible Cause of Confusional State in Cancer PatientsOncology, 2008
- Thrombocytosis and leukocytosis interaction in vascular complications of essential thrombocythemiaBlood, 2008
- Prognostic factors for thrombosis, myelofibrosis, and leukemia in essential thrombocythemia: a study of 605 patientsHaematologica, 2008
- Validation and comparison of contemporary prognostic models in primary myelofibrosisCancer, 2007
- Acute myeloid leukemia: Epidemiology and etiologyCancer, 2006
- Vascular and Neoplastic Risk in a Large Cohort of Patients With Polycythemia VeraJournal of Clinical Oncology, 2005
- Adapting a clinical comorbidity index for use with ICD-9-CM administrative databasesJournal of Clinical Epidemiology, 1992
- Prospective Neuropathologic Study on the Occurrence of Wernicke’s Encephalopathy in Patients With Tumours of the Lymphoid-Hemopoietic Systems1981